{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,4,16]],"date-time":"2023-04-16T04:48:59Z","timestamp":1681620539829},"reference-count":53,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.ijcard.2014.09.095","type":"journal-article","created":{"date-parts":[[2014,10,11]],"date-time":"2014-10-11T01:45:36Z","timestamp":1412991936000},"page":"57-60","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Widened QRS interval and left ventricular systolic depression after propafenone and promazine exposure"],"prefix":"10.1016","volume":"177","author":[{"given":"Roberto","family":"La Rocca","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Ferrari-Toninelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Patan\u00e8","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ijcard.2014.09.095_bb0005","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.ijcard.2014.07.158","article-title":"Cancer multidrug resistance-targeted therapy in both cancer and cardiovascular system with cardiovascular drugs","volume":"176","author":"Patan\u00e8","year":"2014","journal-title":"Int J Cardiol"},{"issue":"3","key":"10.1016\/j.ijcard.2014.09.095_bb0010","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.ijcard.2014.07.129","article-title":"HERG-Targeted therapy in both cancer and cardiovascular system with cardiovascular drugs","volume":"176","author":"Patan\u00e8","year":"2014","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1016\/j.ijcard.2014.09.095_bb0015","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ijcard.2014.04.238","article-title":"Cardiotoxicity: cisplatin and long term cancer survivors","volume":"175","author":"Patan\u00e8","year":"2014","journal-title":"Int J Cardiol"},{"issue":"3","key":"10.1016\/j.ijcard.2014.09.095_bb0020","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.ijcard.2014.07.149","article-title":"Cardiotoxicity: anthracyclines and long term cancer survivors","volume":"176","author":"Patan\u00e8","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ijcard.2014.09.095_bb0025","article-title":"Cardiotoxicity: trastuzumab and cancer survivors","author":"Patan\u00e8","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ijcard.2014.09.095_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2014.08.114","article-title":"Ebola: is there a hope from treatment with cardiovascular drugs?","author":"Patan\u00e8","year":"2014","journal-title":"Int J Cardiol"},{"issue":"3","key":"10.1016\/j.ijcard.2014.09.095_bb0035","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/j.ijcard.2014.07.161","article-title":"ERBB1\/EGFR and ERBB2 (HER2\/neu) \u2014 targeted therapies in cancer and cardiovascular system with cardiovascular drugs","volume":"176","author":"Patan\u00e8","year":"2014","journal-title":"Int J Cardiol"},{"issue":"2","key":"10.1016\/j.ijcard.2014.09.095_bb0040","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ijcard.2014.04.046","article-title":"A challenge in cardiology: the oncosurgery","volume":"174","author":"Patan\u00e8","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ijcard.2014.09.095_bb0045","first-page":"1","article-title":"Insights into cardio-oncology: adrenergic receptor signaling and pathways in breast cancer","volume":"26","author":"Patan\u00e8","year":"2014","journal-title":"Curr Med Res Opin"},{"issue":"6","key":"10.1016\/j.ijcard.2014.09.095_bb0050","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.cardfail.2014.04.014","article-title":"Heart failure and breast cancer: emerging controversies regarding some cardioprotective strategies","volume":"20","author":"Patan\u00e8","year":"2014","journal-title":"J Card Fail"},{"key":"10.1016\/j.ijcard.2014.09.095_bb0055","article-title":"Breast cancer treatment cardioprotective strategies: the King is naked","author":"Patan\u00e8","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ijcard.2014.09.095_bb0060","doi-asserted-by":"crossref","DOI":"10.1007\/s10557-014-6552-7","article-title":"Is there a role for quinazoline-based \u03b1(1)-adrenoceptor antagonists in cardio-oncology?","author":"Patan\u00e8","year":"2014","journal-title":"Card Drugs Ther"},{"issue":"2","key":"10.1016\/j.ijcard.2014.09.095_bb0065","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ijcard.2013.08.139","article-title":"Is vernakalant better or not, compared with other treatments for conversion of acute atrial fibrillation?","volume":"169","author":"Conde","year":"2013","journal-title":"Int J Cardiol"},{"issue":"2","key":"10.1016\/j.ijcard.2014.09.095_bb0070","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ijcard.2012.03.070","article-title":"Interventions for the treatment of atrial fibrillation: a systematic literature review and meta-analysis","volume":"165","author":"Sullivan","year":"2013","journal-title":"Int J Cardiol"},{"issue":"3","key":"10.1016\/j.ijcard.2014.09.095_bb0075","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1016\/j.ijcard.2007.01.017","article-title":"Atrial fibrillation, pharmacological cardioversion and topical ophthalmic beta-blocker use","volume":"126","author":"Patane'","year":"2008","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ijcard.2014.09.095_bb0080","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1023\/A:1009988218428","article-title":"Propafenone","volume":"2","author":"Joglar","year":"1998","journal-title":"Card Elecftrophysiol Rev"},{"issue":"4","key":"10.1016\/j.ijcard.2014.09.095_bb0085","first-page":"476","article-title":"Syncope, widened ORS interval, and left ventricular systolic depression coincident with propafenone therapy for atrial fibrillation","volume":"37","author":"Samaan","year":"2010","journal-title":"Tex Heart Inst J"},{"issue":"6","key":"10.1016\/j.ijcard.2014.09.095_bb0090","doi-asserted-by":"crossref","first-page":"e209","DOI":"10.1016\/S0828-282X(10)70402-5","article-title":"Acute propafenone toxicity after two exposures at standard dosing","volume":"26","author":"Yeung","year":"2010","journal-title":"Can J Cardiol"},{"issue":"1","key":"10.1016\/j.ijcard.2014.09.095_bb0095","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1016\/j.ijcard.2006.12.080","article-title":"Transient syncope, left bundle branch block and first degree atrioventricular block after \u201cpill-in-the-pocket\u201d administration","volume":"126","author":"Patan\u00e8","year":"2008","journal-title":"Int J Cardiol"},{"issue":"2","key":"10.1016\/j.ijcard.2014.09.095_bb0100","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ijcard.2008.11.094","article-title":"Practical considerations about atrial fibrillation and pill-in-the-pocket administration","volume":"140","author":"Patan\u00e8","year":"2010","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1016\/j.ijcard.2014.09.095_bb0105","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S1875-4597(10)60002-1","article-title":"Phenothiazine-type antipsychotics elicit cutaneous analgesia in rats","volume":"48","author":"Chen","year":"2010","journal-title":"Acta Anaesthesiol Taiwan"},{"issue":"7547","key":"10.1016\/j.ijcard.2014.09.095_bb0110","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1136\/bmj.332.7547.960","article-title":"Syncope and falls due to timolol eye drops","volume":"332","author":"Muller","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.ijcard.2014.09.095_bb0115","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1046\/j.1365-2125.1998.t01-1-00768.x","article-title":"Therapeutic drug monitoring: antiarrhythmic drugs","volume":"46","author":"Campbell","year":"1998","journal-title":"Br J Clin Pharmacol"},{"issue":"8","key":"10.1016\/j.ijcard.2014.09.095_bb0120","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1038\/sj.bjp.0705195","article-title":"Contribution of human cytochrome p-450 isoforms to the metabolism of the simplest phenothiazine neuroleptic promazine","volume":"138","author":"W\u00f3jcikowski","year":"2003","journal-title":"Br J Pharmacol"},{"issue":"4","key":"10.1016\/j.ijcard.2014.09.095_bb0125","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1007\/s002100000392","article-title":"Blocking effects of the antiarrhythmic drug propafenone on the HERG potassium channel","volume":"363","author":"Mergenthaler","year":"2001","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"16","key":"10.1016\/j.ijcard.2014.09.095_bb0130","doi-asserted-by":"crossref","first-page":"4587","DOI":"10.1016\/j.bmcl.2013.06.034","article-title":"Are hERG channel blockers also phospholipidosis inducers?","volume":"23","author":"Sun","year":"2013","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.ijcard.2014.09.095_bb0265","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ejphar.2014.06.044","article-title":"hERG trafficking inhibition in drug-induced lethal cardiac arrhythmia","volume":"741","author":"Nogawa","year":"2014","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"10.1016\/j.ijcard.2014.09.095_bb0135","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1016\/j.ijcard.2012.07.009","article-title":"Upregulation of microRNA-1 and microRNA-133 contributes to arsenic-induced cardiac electrical remodeling","volume":"167","author":"Shan","year":"2013","journal-title":"Int J Cardiol"},{"issue":"3","key":"10.1016\/j.ijcard.2014.09.095_bb0140","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.ijcard.2014.04.133","article-title":"New age- and sex-specific criteria for QT prolongation based on rate correction formulas that minimize bias at the upper normal limits","volume":"174","author":"Rautaharju","year":"2014","journal-title":"Int J Cardiol"},{"issue":"3","key":"10.1016\/j.ijcard.2014.09.095_bb0145","doi-asserted-by":"crossref","first-page":"e534","DOI":"10.1016\/j.ijcard.2014.01.111","article-title":"Life-threatening ventricular arrhythmias due to atypical mid-ventricular tako tsubo cardiomyopathy in a patient with chronic QT interval prolongation under anti-psychotic medication","volume":"172","author":"Peters","year":"2014","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1016\/j.ijcard.2014.09.095_bb0150","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1016\/j.ijcard.2013.12.061","article-title":"Serious QT interval prolongation with ranolazine and amiodarone","volume":"172","author":"Tarapu\u00e9s","year":"2014","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1016\/j.ijcard.2014.09.095_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijcard.2013.10.010","article-title":"Andersen\u2013Tawil syndrome: clinical and molecular aspects","volume":"170","author":"Nguyen","year":"2013","journal-title":"Int J Cardiol"},{"issue":"4","key":"10.1016\/j.ijcard.2014.09.095_bb0160","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.ijcard.2013.08.126","article-title":"Time course of electrocardiographic changes in transient left ventricular ballooning syndrome","volume":"169","author":"Bennett","year":"2013","journal-title":"Int J Cardiol"},{"issue":"6","key":"10.1016\/j.ijcard.2014.09.095_bb0165","doi-asserted-by":"crossref","first-page":"5277","DOI":"10.1016\/j.ijcard.2013.08.015","article-title":"Modeling type 3 long QT syndrome with cardiomyocytes derived from patient-specific induced pluripotent stem cells","volume":"168","author":"Ma","year":"2013","journal-title":"Int J Cardiol"},{"issue":"5","key":"10.1016\/j.ijcard.2014.09.095_bb0170","doi-asserted-by":"crossref","first-page":"4975","DOI":"10.1016\/j.ijcard.2013.07.136","article-title":"The impact of drug-related QT prolongation on FDA regulatory decisions","volume":"168","author":"Park","year":"2013","journal-title":"Int J Cardiol"},{"issue":"2","key":"10.1016\/j.ijcard.2014.09.095_bb0175","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.ijcard.2013.03.058","article-title":"Stroke and ventricular arrhythmias","volume":"168","author":"Koppikar","year":"2013","journal-title":"Int J Cardiol"},{"issue":"3","key":"10.1016\/j.ijcard.2014.09.095_bb0180","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1016\/j.ijcard.2013.03.029","article-title":"The utilization of twelve-lead electrocardiography for predicting sudden cardiac death after heart transplantation","volume":"168","author":"Chang","year":"2013","journal-title":"Int J Cardiol"},{"issue":"4","key":"10.1016\/j.ijcard.2014.09.095_bb0185","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.ijcard.2012.09.089","article-title":"New insights into cirrhotic cardiomyopathy","volume":"167","author":"M\u00f8ller","year":"2013","journal-title":"Int J Cardiol"},{"issue":"2","key":"10.1016\/j.ijcard.2014.09.095_bb0190","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ijcard.2012.06.107","article-title":"Electrocardiographic abnormalities and cardiac arrhythmias in structural brain lesions","volume":"167","author":"Katsanos","year":"2013","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1016\/j.ijcard.2014.09.095_bb0195","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ijcard.2012.04.122","article-title":"QT interval prolongation and bradycardia in lithium-induced nephrogenic diabetes insipidus","volume":"162","author":"La Rocca","year":"2012","journal-title":"Int J Cardiol"},{"issue":"3","key":"10.1016\/j.ijcard.2014.09.095_bb0200","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.ijcard.2012.03.071","article-title":"QTc prolongation is associated with impaired right ventricular function and predicts mortality in pulmonary hypertension","volume":"167","author":"Rich","year":"2013","journal-title":"Int J Cardiol"},{"issue":"2","key":"10.1016\/j.ijcard.2014.09.095_bb0205","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ijcard.2012.01.044","article-title":"Warning to \u201cRefeeding syndrome\u201d. Torsades de pointes and ventricular tachyarrhythmia with marked QT prolongation induced by acute glucose injection: report of two cases","volume":"156","author":"Inoue","year":"2012","journal-title":"Int J Cardiol"},{"issue":"2","key":"10.1016\/j.ijcard.2014.09.095_bb0210","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ijcard.2010.10.126","article-title":"Torsade de pointes, QT interval prolongation and renal disease","volume":"149","author":"Patan\u00e8","year":"2011","journal-title":"Int J Cardiol"},{"issue":"2","key":"10.1016\/j.ijcard.2014.09.095_bb0215","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1016\/j.ijcard.2007.11.070","article-title":"QT interval prolongation, torsade de pointes and renal disease","volume":"130","author":"Patan\u00e8","year":"2008","journal-title":"Int J Cardiol"},{"issue":"3","key":"10.1016\/j.ijcard.2014.09.095_bb0220","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1016\/j.ijcard.2013.01.176","article-title":"Atrial fibrillation followed by torsade de pointes degenerated into ventricular fibrillation spontaneously terminated and restored sinus rhythm","volume":"166","author":"Santoro","year":"2013","journal-title":"Int J Cardiol"},{"issue":"3","key":"10.1016\/j.ijcard.2014.09.095_bb0225","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.phrs.2008.01.009","article-title":"The hERG K+ channel: target and antitarget strategies in drug development","volume":"57","author":"Raschi","year":"2008","journal-title":"Pharmacol Res"},{"issue":"3","key":"10.1016\/j.ijcard.2014.09.095_bb0230","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/clpt.2013.234","article-title":"Cardiovascular pharmacogenomics: expectations and practical benefits","volume":"95","author":"Turner","year":"2014","journal-title":"Clin Pharmacol Ther"},{"issue":"8","key":"10.1016\/j.ijcard.2014.09.095_bb0235","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1161\/CIRCULATIONAHA.109.192704","article-title":"Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation","volume":"121","author":"Drew","year":"2010","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ijcard.2014.09.095_bb0270","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.pcad.2010.05.005","article-title":"Prolonged QTc interval in cancer therapeutic drug development: defining arrhythmic risk in malignancy","volume":"53","author":"Brell","year":"2010","journal-title":"Prog Cardiovasc Dis"},{"issue":"5","key":"10.1016\/j.ijcard.2014.09.095_bb0240","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s11936-004-0019-2","article-title":"Antiarrhythmic drugs","volume":"6","author":"Singh","year":"2004","journal-title":"Curr Treat Options Cardiovasc Med"},{"issue":"1","key":"10.1016\/j.ijcard.2014.09.095_bb0245","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1055\/s-2003-38088","article-title":"Minimal myocardial damage after tricyclic neuroleptic overdose \u2014 a case report","volume":"36","author":"Garroni","year":"2003","journal-title":"Pharmacopsychiatry"},{"issue":"9209","key":"10.1016\/j.ijcard.2014.09.095_bb0250","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S0140-6736(00)02035-3","article-title":"QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients","volume":"355","author":"Reilly","year":"2000","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.ijcard.2014.09.095_bb0255","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s40264-014-0170-y","article-title":"Are the safety profiles of antipsychotic drugs used in dementia the same? An updated review of observational studies","volume":"37","author":"Trifir\u00f3","year":"2014","journal-title":"Drug Saf"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527314018154?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527314018154?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T17:20:53Z","timestamp":1538155253000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527314018154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S0167527314018154"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2014.09.095","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Widened QRS interval and left ventricular systolic depression after propafenone and promazine exposure","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2014.09.095","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}